PRDM1-SLC22A16 Fusion FISH Probe
The PRDM1-SLC22A16 Fusion FISH Probe is used to confirm a fusion of the PRDM1 and SLC22A16 genes. The fusion of the PRDM1 and SLC22A16 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PRDM1-SLC22A16-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PRDM1-SLC22A16-20-AQAQ | 20 (40 μL) | 200 μL |
|
PRDM1 Gene Summary
This gene encodes a protein that acts as a repressor of beta-interferon gene expression. The protein binds specifically to the PRDI (positive regulatory domain I element) of the beta-IFN gene promoter. Transcription of this gene increases upon virus induction. Two alternatively spliced transcript variants that encode different isoforms have been reported. [provided by RefSeq, Jul 2008]
Gene Name: PR/SET Domain 1
Chromosome: CHR6: 106534194 -106557814
Locus: 6q21
SLC22A16 Gene Summary
This gene encodes a member of the organic zwitterion transporter protein family which transports carnitine. The encoded protein has also been shown to transport anticancer drugs like bleomycin (PMID: 20037140) successful treatment has been correlated with the level of activity of this transporter in tumor cells. [provided by RefSeq, Dec 2011]
Gene Name: Solute Carrier Family 22 Member 16
Chromosome: CHR6: 110745906 -110797844
Locus: 6q21-q22.1
Gene Diseases
The PRDM1 SLC22A16 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|